Firazyr Solution For Injection 10Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

FIRAZYR: Solution for injection (10mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

ICATIBANT is a protein used for the treatment of angioedema attacks.

In-Depth Information

FIRAZYR 30mg/3ml Solution for Injection

NDC: 540920702
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Hereditary Angioedema

Sometimes used for but not FDA approved for the following conditions:
ACE-inhibitor Induced Angioedema

Storage Information
Store in original package until time of use
Do not freeze
Store between 36 to 77 degrees F
FIRAZYR 30mg/3ml Solution for Injection

Reported Side Effects for FIRAZYR 30mg/3ml Solution for Injection

Skin Rash Incidence:
>1.0%*
Severity: MILD
Onset: EARLY
Lightheadedness Incidence:
3.0%*
Severity: MILD
Onset: EARLY
Fever Incidence:
4.0%*
Severity: MILD
Onset: EARLY
Elevated Hepatic Enzymes Incidence:
4.0%*
Severity: MODERATE
Onset: DELAYED
Injection Site Reaction Incidence:
97.0%*
Severity: MILD
Onset: RAPID
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with FIRAZYR

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5